Claritin and Dostinex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Claritin (loratadine) and Dostinex (cabergoline). Common drug interactions include carotid artery disease among females and bladder spasm among males.

The phase IV clinical study analyzes what interactions people have when they take Claritin and Dostinex. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,316 Claritin users. Check the latest studies of Claritin.

What is Dostinex?

Dostinex has active ingredients of cabergoline. It is often used in prolactinoma. eHealthMe is studying from 3,064 Dostinex users. Check the latest studies of Dostinex.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 24, 2026

13 people who take Claritin and Dostinex together, and have interactions are studied.

Claritin and Dostinex drug interactions.

What are the common drug interactions of Claritin and Dostinex, by gender? *:

female:

Carotid artery disease
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Diabetic coma
Dizziness
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Hot flush (sudden feelings of heat)
Hyperhidrosis (abnormally increased sweating)
Injection site induration

male:

Bladder spasm
Catheter site pain
Catheter site related reaction
Urethral spasm (urethral muscle spasm)
Urinary retention (the inability to completely or partially empty the bladder)

What are the common drug interactions of Claritin and Dostinex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Diabetic coma
Drug ineffective
Pancreatitis (inflammation of pancreas)
Type 2 diabetes mellitus
Abnormal labour
Oedema (fluid collection in tissue)
Brain neoplasm (tumour of brain)

40-49:

Migraine (headache)

50-59:

n/a

60+:

Carotid artery disease
Injection site induration
Injection site inflammation
Insulin-like growth factor increased
Muscle spasms (muscle contraction)
Pituitary tumour benign

What are the existing conditions these people have? *

Weight Decreased: 1 person, 7.69%
Type 2 Diabetes: 1 person, 7.69%
Thyroid Diseases: 1 person, 7.69%
Seasonal Allergy (allergic condition due to certain season): 1 person, 7.69%
Rickets (softening of bones): 1 person, 7.69%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 7.69%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 7.69%
Pituitary Tumor: 1 person, 7.69%
Mixed Connective Tissue Disease (an autoimmune disease, in which the body's defence system attacks itself): 1 person, 7.69%
Hypersensitivity: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Claritin and Dostinex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously